Related Experiment Video
Updated: Oct 6, 2025

07:51
Standardized Hemorrhagic Shock Induction Guided by Cerebral Oximetry and Extended Hemodynamic Monitoring in Pigs
Published on: May 21, 2019
7.5K
Pathophysiology of hemorrhagic shock
1Wilford and Kate Bailey Small Animal Teaching Hospital, Auburn University, Auburn, Alabama, USA.
Summary
Hemorrhagic shock, a leading cause of trauma death, involves inadequate cellular energy production. Understanding its pathophysiology is crucial for developing effective hemostatic and resuscitation strategies.
Area of Science:
- Physiology
- Trauma Medicine
- Pathophysiology
Background:
- Hemorrhagic shock is a critical condition characterized by hemodynamic instability and cellular hypoxia.
- It can result from various traumatic and non-traumatic causes of bleeding.
- This condition can lead to organ damage and mortality.
Purpose of the Study:
- To review the pathophysiology of hemorrhagic shock.
- To emphasize the importance of understanding shock mechanisms for current and future treatments.
- To highlight the link between hemorrhage and acute traumatic coagulopathy.
Main Methods:
- This is a review article, synthesizing existing knowledge.
- It focuses on the physiological responses to acute hemorrhage.
- The review examines the development and exacerbation of hemorrhagic shock.
Main Results:
- Hemorrhagic shock leads to inadequate cellular energy production.
- Physiological responses vary based on hemorrhage magnitude and rate.
- Acute traumatic coagulopathy can worsen hemorrhagic shock.
Conclusions:
- Hemorrhagic shock is a primary cause of death in trauma patients.
- Understanding shock pathophysiology is essential for effective hemostatic and resuscitation strategies.
- This knowledge is foundational for developing novel therapeutic interventions.
Related Concept Videos
Blood Pressure Imbalances and Circulatory Shock
1.1K
Disorders affecting blood volume, vascular tone, or vascular function can disrupt vascular homeostasis, including conditions like hypertension, hemorrhage, and shock.
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...
1.1K
Introduction to Hemostasis
9.5K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
9.5K
Extrinsic and Intrinsic Pathways of Hemostasis
9.8K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
9.8K
Disorders of Hemostasis
1.3K
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
1.3K
Vascular Spasm
2.3K
The vascular phase, also known as vasospasm, is the initial stage of hemostasis, crucial for preventing excessive bleeding when a blood vessel is injured. After a vessel is cut, nerves in the damaged area trigger pain and other sensory impulses. Simultaneously, the smooth muscles in the vessel wall contract, resulting in a vascular spasm. This contraction reduces the vessel's diameter at the injury site, slowing or stopping blood loss through the vessel wall. Vascular spasms typically last...
2.3K
Coagulation
7.8K
The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
7.8K

